Medytox Files ITC Complaint Against Hugel to Block Import of Botox Follow-On
LexBlog IP
APRIL 5, 2022
botulinum and related highly confidential manufacturing documents,” to develop Hugel’s product. The complaint alleges that Hugel expects to obtain approval and launch its product in the U.S. The complaint alleges that “Hugel misappropriated Medytox’s trade secrets by stealing its proprietary strain of C.
Let's personalize your content